Implantable cardioverter defibrillators (ICDs) significantly contribute to the prevention of
sudden cardiac death in selected patients. However, it is essential to identify those who are …

Background As patients derive variable benefit from generator changes (GCs) of
implantable cardioverter‐defibrillators (ICDs) with an original primary prevention (PP) …

Aims The safety of omitting implantable cardioverter-defibrillator (ICD) generator
replacement in patients with no prior appropriate therapy, comorbid conditions, and …

Randomized trials inform the use of implantable cardioverter–defibrillators (ICDs) for
prevention of sudden cardiac death, yet management of patients considering ICD generator …

Introduction Cardiac resynchronization defibrillator (CRT‐D) as primary prevention is known
to reduce mortality. At the time of replacement, higher age and comorbidities may attenuate …

Background Every 4–7 years an implantable cardioverter defibrillator (ICD) pulse generator
must be replaced surgically. This procedure is not without risk. In some cases, the risk …

Background: Uncertainty still surrounds implantable cardioverter defibrillator (ICD) generator
change at time of elective replacement indicator, in primary prevention patients with …

Background Past clinical trials have shown the benefit of implantable cardioverter-
defibrillators (ICDs) for reducing sudden cardiac death in at-risk patients. However, heart …

Abstract Background Implantable cardioverter defibrillators (ICDs) are indicated for the
primary prevention of sudden cardiac death in patients with reduced left ventricular ejection …

Multiple clinical trials have demonstrated the mortality benefit of implantable cardioverter-
defibrillator (ICD) therapy for the primary prevention of sudden cardiac death, expanding the …